C Arthur Paul News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from C arthur paul. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In C Arthur Paul Today - Breaking & Trending Today
Antiviral drug Clevira repurposed for treatment of mild to moderate COVID-19 cases Photo: Pexels Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday. The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. The drug has also proved to be safe on liver and kidney parameters, it said. Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate COVID-19 cases, the Chennai-based pharmaceutical company said. ....
India News: NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate Covid-19 cases, its m. ....
New Delhi: Clevira, a drug primarily developed to treat dengue, has been repurposed as a supportive treatment for mild to moderate COVID-19 cases, its ....
Antiviral drug Clevira repurposed for treating mild to moderate COVID-19 patients The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. Share Via Email | A+A A- Beds lie inside an indoor stadium converted into COVID-19 treatment center for emergencies in the wake of the spike in the numbers of positive coronavirus cases in Srinagar. (Photo | AP) By PTI NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday. The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. ....
Share Bhubaneswar: Apex Laboratories Private Limited, a Chennai based pharmaceutical company known for its cutting-edge research and innovation, introduces Clevira, an antiviral herbal formulation. Clevira was developed primarily to treat dengue patients in 2017. Last year as the COVID-19 cases surged in the country, it was repurposed as supportive treatment for mild to moderate COVID symptoms. The product is available across India and is priced at Rs 11 per tablet. A clinical trial was conducted on 100 people in May-June 2020 and the results were promising. During the 30 days trial, conducted at Government Medical College, Omandurar Government Estate Chennai, after approval from the Tamil Nadu government, the selected 100 participants were randomized into 2 Groups with 50 patients in each: the control group comprised of patients diagnosed with SARS-CoV-2 infection received standard care treatment as per hospital regulation as well as the WHO/ICMR guidelines. The t ....